FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / Virol Sin / Host cell restriction factors of equine infectious anemia vi...
Virologica Sinica2023; 38(4); 485-496; doi: 10.1016/j.virs.2023.07.001

Host cell restriction factors of equine infectious anemia virus.

Abstract: Equine infectious anemia virus (EIAV) is a member of the lentivirus genus in the Retroviridae family and is considered an animal model for HIV/AIDS research. An attenuated EIAV vaccine, which was successfully developed in the 1970s by classical serial passage techniques, is the first and only lentivirus vaccine that has been widely used to date. Restriction factors are cellular proteins that provide an early line of defense against viral replication and spread by interfering with various critical steps in the viral replication cycle. However, viruses have evolved specific mechanisms to overcome these host barriers through adaptation. The battle between the viruses and restriction factors is actually a natural part of the viral replication process, which has been well studied in human immunodeficiency virus type 1 (HIV-1). EIAV has the simplest genome composition of all lentiviruses, making it an intriguing subject for understanding how the virus employs its limited viral proteins to overcome restriction factors. In this review, we summarize the current literature on the interactions between equine restriction factors and EIAV. The features of equine restriction factors and the mechanisms by which the EIAV counteract the restriction suggest that lentiviruses employ diverse strategies to counteract innate immune restrictions. In addition, we present our insights on whether restriction factors induce alterations in the phenotype of the attenuated EIAV vaccine.
Copyright © 2023 The Authors. Publishing services by Elsevier B.V. All rights reserved.
Get Full Text
Publication Date: 2023-07-05 PubMed ID: 37419416PubMed Central: PMC10436108DOI: 10.1016/j.virs.2023.07.001Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article
  • Review

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research paper is a review on the interactions of host cell restriction factors and the equine infectious anemia virus (EIAV), a lentivirus used as an animal model for HIV/AIDS research. It explores the mechanisms of how the virus overcomes these barriers and potential effects on an attenuated EIAV vaccine.

Overview of the Research Paper

The paper studies the interactions between EIAV and restriction factors – cellular proteins that form the first line of protection against viral replication and spread. This review aims to:

  • Understand how EIAV employs its viral proteins to overcome restriction factors.
  • Elucidate the characteristics of equine restriction factors.
  • Analyze how EIAV overcomes these restrictions.
  • Inquire if restriction factors induce alterations in the phenotype of the attenuated EIAV vaccine.

EIAV and Restriction Factors

EIAV, a member of lentivirus in the Retroviridae family, is said to have the simplest genome composition among all lentiviruses. This simplicity makes EIAV a fascinating subject in studying how the virus uses its minimal proteins to overcome restriction factors.

Restriction factors are proteins that obstruct viral replication and spread at various stages of the viral replication cycle to protect the host cell. They can hinder viruses, but viruses have developed specific adaptations to overcome these obstacles.

Battle Between Viruses and Restriction Factors

The interaction between viruses and restriction factors is a natural part of the viral replication process. For instance, human immunodeficiency virus type 1 (HIV-1) has been thoroughly studied on the same. This is a battle of survival where host cells aim to safeguard from viruses and viruses strive to infect and multiply in the host cells successfully.

Lentiviruses’ Counteractions

Lentiviruses employ multiple strategies to overcome inherent immune restrictions. Understanding how EIAV counteracts restriction factors will shed light on these strategies, which could aid in developing more effective treatments for diseases like HIV/AIDS.

Impact on EIAV Vaccine

Lastly, the review looks into whether these restriction factors could potentially alter the phenotype of the attenuated EIAV vaccine that has been in use since the 1970s. This helps understand whether the effectiveness of the vaccine is compromised over time due to this interaction and what measures could be taken to enhance its potency.

Cite This Article

APA
Wang XF, Zhang X, Ma W, Li J, Wang X. (2023). Host cell restriction factors of equine infectious anemia virus. Virol Sin, 38(4), 485-496. https://doi.org/10.1016/j.virs.2023.07.001

Publication

Virologica Sinica
ISSN: 1995-820X
NlmUniqueID: 101514185
Country: Netherlands
Language: English
Volume: 38
Issue: 4
Pages: 485-496
PII: S1995-820X(23)00081-0

Researcher Affiliations

Wang, Xue-Feng
  • State Key Laboratory for Animal Disease Control and Prevention, Harbin Veterinary Research Institute of Chinese Academy of Agricultural Sciences, Harbin 150069, China.
Zhang, Xiangmin
  • State Key Laboratory for Animal Disease Control and Prevention, Harbin Veterinary Research Institute of Chinese Academy of Agricultural Sciences, Harbin 150069, China.
Ma, Weiwei
  • State Key Laboratory for Animal Disease Control and Prevention, Harbin Veterinary Research Institute of Chinese Academy of Agricultural Sciences, Harbin 150069, China.
Li, Jiwei
  • State Key Laboratory for Animal Disease Control and Prevention, Harbin Veterinary Research Institute of Chinese Academy of Agricultural Sciences, Harbin 150069, China.
Wang, Xiaojun
  • State Key Laboratory for Animal Disease Control and Prevention, Harbin Veterinary Research Institute of Chinese Academy of Agricultural Sciences, Harbin 150069, China. Electronic address: wangxiaojun@caas.cn.

MeSH Terms

  • Horses
  • Animals
  • Humans
  • Infectious Anemia Virus, Equine / genetics
  • Antiviral Restriction Factors
  • Viral Proteins / metabolism
  • Virus Replication
  • HIV-1 / genetics

Conflict of Interest Statement

Conflict of interest The authors declare that there are no conflicts of interest.

References

This article includes 168 references
  1. Aebi M, Fah J, Hurt N, Samuel CE, Thomis D, Bazzigher L, Pavlovic J, Haller O, Staeheli P. Cdna structures and regulation of two interferon-induced human mx proteins.. Mol. Cell Biol. 1989;9:5062–5072.
    pmc: PMC363658pubmed: 2481229
  2. Ahmad I, Li S, Li R, Chai Q, Zhang L, Wang B, Yu C, Zheng YH. The retroviral accessory proteins s2, nef, and glycoma use similar mechanisms for antagonizing the host restriction factor serinc5.. J. Biol. Chem. 2019;294:7013–7024.
    pmc: PMC6497950pubmed: 30862674
  3. Ajoge HO, Renner TM, Belanger K, Greig M, Dankar S, Kohio HP, Coleman MD, Ndashimye E, Arts EJ, Langlois MA, Barr SD. Antiretroviral apobec3 cytidine deaminases alter hiv-1 provirus integration site profiles.. Nat. Commun. 2023;14:16.
    pmc: PMC9832166pubmed: 36627271
  4. Ara A, Love RP, Chelico L. Different mutagenic potential of hiv-1 restriction factors apobec3g and apobec3f is determined by distinct single-stranded DNA scanning mechanisms.. PLoS Pathog. 2014;10.
    pmc: PMC3961392pubmed: 24651717
  5. Bai B, Wang XF, Zhang M, Na L, Zhang X, Zhang H, Yang Z, Wang X. The n-glycosylation of equine tetherin affects antiviral activity by regulating its subcellular localization.. Viruses 2020;12:220.
    pmc: PMC7077275pubmed: 32079099
  6. Beitari S, Ding S, Pan Q, Finzi A, Liang C. Effect of hiv-1 env on serinc5 antagonism.. J. Virol. 2017;91.
    pmc: PMC5286904pubmed: 27928004
  7. Billcliff PG, Rollason R, Prior I, Owen DM, Gaus K, Banting G. Cd317/tetherin is an organiser of membrane microdomains.. J. Cell Sci. 2013;126:1553–1564.
    pmc: PMC3647434pubmed: 23378022
  8. Blondeau C, Pelchen-Matthews A, Mlcochova P, Marsh M, Milne RS, Towers GJ. Tetherin restricts herpes simplex virus 1 and is antagonized by glycoprotein m.. J. Virol. 2013;87:13124–13133.
    pmc: PMC3838283pubmed: 24067975
  9. Bogerd HP, Tallmadge RL, Oaks JL, Carpenter S, Cullen BR. Equine infectious anemia virus resists the antiretroviral activity of equine apobec3 proteins through a packaging-independent mechanism.. J. Virol. 2008;82:11889–11901.
    pmc: PMC2583693pubmed: 18818324
  10. Braun BA, Marcovitz A, Camp JG, Jia R, Bejerano G. Mx1 and mx2 key antiviral proteins are surprisingly lost in toothed whales. Proceedings of the National Academy of Sciences U S A Vol. 112. 2015. pp. 8036–8040.
    pmc: PMC4491785pubmed: 26080416
  11. Businger R, Deutschmann J, Gruska I, Milbradt J, Wiebusch L, Gramberg T, Schindler M. Human cytomegalovirus overcomes samhd1 restriction in macrophages via pul 97.. Nat Microbiol. 2019;4:2260–2272.
    pubmed: 31548682
  12. Cai W-G, Na L, Liu D-Q, Ma J, Yin X, Zhang Z-L, Ai Y-W, Wang X-J. The cloning of equine trim5α gene and the anti-equine infectious anemia virus activity of the protein.. Chin. J. Prev. Vet. Med. 2014;36:620–623. (in Chinese).
  13. Camara RJF, Bueno BL, Resende CF, Balasuriya UBR, Sakamoto SM, Reis J. Viral Diseases that Affect Donkeys and Mules.. Animals (Basel) 2020 p. 10.
    pmc: PMC7760297pubmed: 33255568
  14. Celestino M, Calistri A, Del Vecchio C, Salata C, Chiuppesi F, Pistello M, Borsetti A, Palu G, Parolin C. Feline tetherin is characterized by a short n-terminal region and is counteracted by the feline immunodeficiency virus envelope glycoprotein.. J. Virol. 2012;86:6688–6700.
    pmc: PMC3393548pubmed: 22514338
  15. Chan YL, Chang TH, Liao CL, Lin YL. The cellular antiviral protein viperin is attenuated by proteasome-mediated protein degradation in Japanese encephalitis virus-infected cells.. J. Virol. 2008;82:10455–10464.
    pmc: PMC2573197pubmed: 18768981
  16. Chande A, Cuccurullo EC, Rosa A, Ziglio S, Carpenter S, Pizzato M. S2 from equine infectious anemia virus is an infectivity factor which counteracts the retroviral inhibitors serinc5 and serinc3. Proceedings of the National Academy of Sciences U S A Vol. 113. 2016. pp. 13197–13202.
    pmc: PMC5135340pubmed: 27803322
  17. Cheng AZ, Moraes SN, Shaban NM, Fanunza E, Bierle CJ, Southern PJ, Bresnahan WA, Rice SA, Harris RS. Apobecs and herpesviruses.. Viruses 2021;13:390.
    pmc: PMC7998176pubmed: 33671095
  18. Chiramel AI, Meyerson NR, McNally KL, Broeckel RM, Montoya VR, Mendez-Solis O, Robertson SJ, Sturdevant GL, Lubick KJ, Nair V, Youseff BH, Ireland RM, Bosio CM, Kim K, Luban J, Hirsch VM, Taylor RT, Bouamr F, Sawyer SL, Best SM. Trim5alpha restricts flavivirus replication by targeting the viral protease for proteasomal degradation.. Cell Rep. 2019;27:3269–3283 e3266.
    pmc: PMC8666140pubmed: 31189110
  19. Coggins SA, Mahboubi B, Schinazi RF, Kim B. Samhd1 functions and human diseases.. Viruses 2020;12:382.
    pmc: PMC7232136pubmed: 32244340
  20. Colomer-Lluch M, Ruiz A, Moris A, Prado JG. Restriction factors: from intrinsic viral restriction to shaping cellular immunity against hiv-1.. Front. Immunol. 2018;9:2876.
    pmc: PMC6291751pubmed: 30574147
  21. Cook RF, Leroux C, Issel CJ. Equine infectious anemia and equine infectious anemia virus in 2013: a review.. Vet. Microbiol. 2013;167:181–204.
    pubmed: 24183747
  22. Cook SJ, Cook RF, Montelaro RC, Issel CJ. Differential responses of equus caballus and equus asinus to infection with two pathogenic strains of equine infectious anemia virus.. Vet. Microbiol. 2001;79:93–109.
    pubmed: 11230932
  23. Costa VMD, Cursino AE, Franco Luiz APM, Braz GF, Cavalcante PH, Souza CA, Simplicio K, Drumond BP, Lima MT, Teixeira BM, Kroon EG. Equine infectious anemia virus (eiav): evidence of circulation in donkeys from the brazilian northeast region.. J. Equine Vet. Sci. 2022;108.
    pubmed: 34800799
  24. Craigo JK, Montelaro RC. Lessons in aids vaccine development learned from studies of equine infectious, anemia virus infection and immunity.. Viruses 2013;5:2963–2976.
    pmc: PMC3967156pubmed: 24316675
  25. Crameri M, Bauer M, Caduff N, Walker R, Steiner F, Franzoso FD, Gujer C, Boucke K, Kucera T, Zbinden A, Munz C, Fraefel C, Greber UF, Pavlovic J. Mxb is an interferon-induced restriction factor of human herpesviruses.. Nat. Commun. 2018;9:1980.
    pmc: PMC5958057pubmed: 29773792
  26. Cribier A, Descours B, Valadao AL, Laguette N, Benkirane M. Phosphorylation of samhd1 by cyclin a2/cdk1 regulates its restriction activity toward hiv-1.. Cell Rep. 2013;3:1036–1043.
    pubmed: 23602554
  27. Cuadrado E, Jansen MH, Anink J, De Filippis L, Vescovi AL, Watts C, Aronica E, Hol EM, Kuijpers TW. Chronic exposure of astrocytes to interferon-alpha reveals molecular changes related to aicardi-goutieres syndrome.. Brain 2013;136:245–258.
    pubmed: 23365100
  28. De Meo S, Dell'Oste V, Molfetta R, Tassinari V, Lotti LV, Vespa S, Pignoloni B, Covino DA, Fantuzzi L, Bona R, Zingoni A, Nardone I, Biolatti M, Coscia A, Paolini R, Benkirane M, Edfors F, Sandalova T, Achour A, Hiscott J, Landolfo S, Santoni A, Cerboni C. Samhd1 phosphorylation and cytoplasmic relocalization after human cytomegalovirus infection limits its antiviral activity.. PLoS Pathog. 2020;16.
    pmc: PMC7544099pubmed: 32986788
  29. Delviks-Frankenberry KA, Desimmie BA, Pathak VK. Structural insights into APOBEC3-mediated lentiviral restriction.. Viruses 2020;12:587.
    pmc: PMC7354603pubmed: 32471198
  30. Desrosiers RC. The failure of aids vaccine efficacy trials: where to go from here.. J. Virol. 2023;97.
    pmc: PMC10062124pubmed: 36916947
  31. Deutschmann J, Gramberg T. Samhd1 ... And viral ways around it.. Viruses 2021;13:395.
    pmc: PMC7999308pubmed: 33801276
  32. Dube M, Roy BB, Guiot-Guillain P, Binette J, Mercier J, Chiasson A, Cohen EA. Antagonism of tetherin restriction of hiv-1 release by vpu involves binding and sequestration of the restriction factor in a perinuclear compartment.. PLoS Pathog. 2010;6.
    pmc: PMC2851737pubmed: 20386718
  33. Fagerness AJ, Flaherty MT, Perry ST, Jia B, Payne SL, Fuller FJ. The s2 accessory gene of equine infectious anemia virus is essential for expression of disease in ponies.. Virology 2006;349:22–30.
    pubmed: 16503341
  34. Fenwick MK, Su D, Dong M, Lin H, Ealick SE. Structural basis of the substrate selectivity of viperin.. Biochemistry 2020;59:652–662.
    pmc: PMC7920147pubmed: 31917549
  35. Firrito C, Bertelli C, Vanzo T, Chande A, Pizzato M. Serinc5 as a new restriction factor for human immunodeficiency virus and murine leukemia virus.. Annu Rev Virol. 2018;5:323–340.
    pubmed: 30265629
  36. Gaba A, Flath B, Chelico L. Examination of the apobec3 barrier to cross species transmission of primate lentiviruses.. Viruses 2021;13:1084.
    pmc: PMC8228377pubmed: 34200141
  37. Gaudaire D, Lecouturier F, Poncon N, Morilland E, Laugier C, Zientara S, Hans A. Molecular characterization of equine infectious anaemia virus from a major outbreak in southeastern France.. Transbound Emerg Dis. 2018;65:e7–e13.
    pubmed: 28503813
  38. Gizzi AS, Grove TL, Arnold JJ, Jose J, Jangra RK, Garforth SJ, Du Q, Cahill SM, Dulyaninova NG, Love JD, Chandran K, Bresnick AR, Cameron CE, Almo SC. A naturally occurring antiviral ribonucleotide encoded by the human genome.. Nature 2018;558:610–614.
    pmc: PMC6026066pubmed: 29925952
  39. Goffinet C, Allespach I, Homann S, Tervo HM, Habermann A, Rupp D, Oberbremer L, Kern C, Tibroni N, Welsch S, Krijnse-Locker J, Banting G, Krausslich HG, Fackler OT, Keppler OT. Hiv-1 antagonism of cd317 is species specific and involves vpu-mediated proteasomal degradation of the restriction factor.. Cell Host Microbe 2009;5:285–297.
    pubmed: 19286137
  40. Goldstone DC, Ennis-Adeniran V, Hedden JJ, Groom HC, Rice GI, Christodoulou E, Walker PA, Kelly G, Haire LF, Yap MW, de Carvalho LP, Stoye JP, Crow YJ, Taylor IA, Webb M. Hiv-1 restriction factor samhd1 is a deoxynucleoside triphosphate triphosphohydrolase.. Nature 2011;480:379–382.
    pubmed: 22056990
  41. Goujon C, Schaller T, Galao RP, Amie SM, Kim B, Olivieri K, Neil SJ, Malim MH. Evidence for ifnalpha-induced, samhd1-independent inhibitors of early hiv-1 infection.. Retrovirology 2013;10:23.
    pmc: PMC3598776pubmed: 23442224
  42. Goujon C, Moncorge O, Bauby H, Doyle T, Ward CC, Schaller T, Hue S, Barclay WS, Schulz R, Malim MH. Human mx2 is an interferon-induced post-entry inhibitor of hiv-1 infection.. Nature 2013;502:559–562.
    pmc: PMC3808269pubmed: 24048477
  43. Guerrero S, Libre C, Batisse J, Mercenne G, Richer D, Laumond G, Decoville T, Moog C, Marquet R, Paillart JC. Translational regulation of apobec3g mrna by vif requires its 5'utr and contributes to restoring hiv-1 infectivity.. Sci. Rep. 2016;6.
    pmc: PMC5171582pubmed: 27996044
  44. Guo G, Wang Y, Hu XM, Li ZR, Tan J, Qiao WT. Human schlafen 11 exploits codon preference discrimination to attenuate viral protein synthesis of prototype foamy virus (pfv). Virology 2021;555:78–88.
    pubmed: 33465725
  45. Haider T, Snetkov X, Jolly C. HIV envelope tail truncation confers resistance to serinc5 restriction.. Proceedings of the National Academy of Sciences U S A Vol. 118. 2021.
    pmc: PMC8166163pubmed: 34001619
  46. Hammond SA, Li F, McKeon BM Sr, Cook SJ, Issel CJ, Montelaro RC. Immune responses and viral replication in long-term inapparent carrier ponies inoculated with equine infectious anemia virus.. J. Virol. 2000;74:5968–5981.
    pmc: PMC112093pubmed: 10846078
  47. Harris RS, Liddament MT. Retroviral restriction by apobec proteins.. Nat. Rev. Immunol. 2004;4:868–877.
    pubmed: 15516966
  48. Hrecka K, Hao C, Gierszewska M, Swanson SK, Kesik-Brodacka M, Srivastava S, Florens L, Washburn MP, Skowronski J. Vpx relieves inhibition of hiv-1 infection of macrophages mediated by the samhd1 protein.. Nature 2011;474:658–661.
    pmc: PMC3179858pubmed: 21720370
  49. Hsu JC, Laurent-Rolle M, Pawlak JB, Xia H, Kunte A, Hee JS, Lim J, Harris LD, Wood JM, Evans GB, Shi PY, Grove TL, Almo SC, Cresswell P. Viperin triggers ribosome collision-dependent translation inhibition to restrict viral replication.. Mol. Cell. 2022;82:1631–1642 e1636.
    pmc: PMC9081181pubmed: 35316659
  50. Hultquist JF, Lengyel JA, Refsland EW, LaRue RS, Lackey L, Brown WL, Harris RS. Human and rhesus apobec3d, apobec3f, apobec3g, and apobec3h demonstrate a conserved capacity to restrict vif-deficient hiv-1.. J. Virol. 2011;85:11220–11234.
    pmc: PMC3194973pubmed: 21835787
  51. Hyeon S, Lee MK, Kim YE, Lee GM, Ahn JH. Degradation of samhd1 restriction factor through cullin-ring e3 ligase complexes during human cytomegalovirus infection.. Front. Cell. Infect. Microbiol. 2020;10:391.
    pmc: PMC7406573pubmed: 32850489
  52. Iwabu Y, Fujita H, Kinomoto M, Kaneko K, Ishizaka Y, Tanaka Y, Sata T, Tokunaga K. Hiv-1 accessory protein vpu internalizes cell-surface bst-2/tetherin through transmembrane interactions leading to lysosomes.. J. Biol. Chem. 2009;284:35060–35072.
    pmc: PMC2787367pubmed: 19837671
  53. Iwatani Y, Chan DS, Wang F, Stewart-Maynard K, Sugiura W, Gronenborn AM, Rouzina I, Williams MC, Musier-Forsyth K, Levin JG. Deaminase-independent inhibition of hiv-1 reverse transcription by apobec3g.. Nucleic Acids Res. 2007;35:7096–7108.
    pmc: PMC2175344pubmed: 17942420
  54. Ji S, Na L, Ren H, Wang Y, Wang X. Equine myxovirus resistance protein 2 restricts lentiviral replication by blocking nuclear uptake of capsid protein.. J. Virol. 2018;92.
    pmc: PMC6146692pubmed: 29743377
  55. Jimenez-Guardeno JM, Apolonia L, Betancor G, Malim MH. Immunoproteasome activation enables human trim5alpha restriction of hiv-1.. Nat Microbiol. 2019;4:933–940.
    pmc: PMC6544544pubmed: 30886358
  56. Jin C, Peng X, Liu F, Cheng L, Xie T, Lu X, Wu H, Wu N. Interferon-induced sterile alpha motif and histidine/aspartic acid domain-containing protein 1 expression in astrocytes and microglia is mediated by microrna-181a.. AIDS 2016;30:2053–2064.
    pubmed: 27219130
  57. Jin S, Tian S, Luo M, Xie W, Liu T, Duan T, Wu Y, Cui J. Tetherin suppresses type i interferon signaling by targeting mavs for ndp52-mediated selective autophagic degradation in human cells.. Mol. Cell. 2017;68:308–322 e304.
    pubmed: 28965816
  58. Jouvenet N, Neil SJ, Zhadina M, Zang T, Kratovac Z, Lee Y, McNatt M, Hatziioannou T, Bieniasz PD. Broad-spectrum inhibition of retroviral and filoviral particle release by tetherin.. J. Virol. 2009;83:1837–1844.
    pmc: PMC2643743pubmed: 19036818
  59. Kaletsky RL, Francica JR, Agrawal-Gamse C, Bates P. Tetherin-mediated restriction of filovirus budding is antagonized by the ebola glycoprotein. Proceedings of the National Academy of Sciences U S A Vol. 106. 2009. pp. 2886–2891.
    pmc: PMC2650360pubmed: 19179289
  60. Kane M, Yadav SS, Bitzegeio J, Kutluay SB, Zang T, Wilson SJ, Schoggins JW, Rice CM, Yamashita M, Hatziioannou T, Bieniasz PD. Mx2 is an interferon-induced inhibitor of hiv-1 infection.. Nature 2013;502:563–566.
    pmc: PMC3912734pubmed: 24121441
  61. Kewalramani VN, Emerman M. Vpx association with mature core structures of hiv-2.. Virology 1996;218:159–168.
    pubmed: 8615019
  62. Kim ET, Weitzman MD. Schlafens can put viruses to sleep.. Viruses 2022;14:442.
    pmc: PMC8875196pubmed: 35216035
  63. Kono Y, Hirasawa K, Fukunaga Y, Taniguchi T. Recrudescence of equine infectious anemia by treatment with immunosuppressive drugs.. Natl. Inst. Anim. Health Q. 1976;16:8–15.
    pubmed: 177894
  64. Kupzig S, Korolchuk V, Rollason R, Sugden A, Wilde A, Banting G. Bst-2/hm1.24 is a raft-associated apical membrane protein with an unusual topology.. Traffic 2003;4:694–709.
    pubmed: 12956872
  65. Laguette N, Sobhian B, Casartelli N, Ringeard M, Chable-Bessia C, Segeral E, Yatim A, Emiliani S, Schwartz O, Benkirane M. Samhd1 is the dendritic- and myeloid-cell-specific hiv-1 restriction factor counteracted by vpx.. Nature 2011;474:654–657.
    pmc: PMC3595993pubmed: 21613998
  66. Lai KK, Munro JB, Shi G, Majdoul S, Compton AA, Rein A. Restriction of influenza a virus by serinc5.. mBio 2022;13.
    pmc: PMC9765469pubmed: 36409124
  67. Le Tortorec A, Neil SJ. Antagonism to and intracellular sequestration of human tetherin by the human immunodeficiency virus type 2 envelope glycoprotein.. J. Virol. 2009;83:11966–11978.
    pmc: PMC2772693pubmed: 19740980
  68. Lee EJ, Seo JH, Park JH, Vo TTL, An S, Bae SJ, Le H, Lee HS, Wee HJ, Lee D, Chung YH, Kim JA, Jang MK, Ryu SH, Yu E, Jang SH, Park ZY, Kim KW. Samhd1 acetylation enhances its deoxynucleotide triphosphohydrolase activity and promotes cancer cell proliferation.. Oncotarget 2017;8:68517–68529.
    pmc: PMC5620274pubmed: 28978134
  69. Lenzi GM, Domaoal RA, Kim DH, Schinazi RF, Kim B. Kinetic variations between reverse transcriptases of viral protein x coding and noncoding lentiviruses.. Retrovirology 2014;11:111.
    pmc: PMC4282736pubmed: 25524560
  70. Leroux C, Cadore JL, Montelaro RC. Equine infectious anemia virus (eiav): what has hiv's country cousin got to tell us?. Vet. Res. 2004;35:485–512.
    pubmed: 15236678
  71. Li J, Zhang X, Bai B, Zhang M, Ma W, Lin Y, Wang X, Wang XF. Identification of a novel post-transcriptional transactivator from the equine infectious anemia virus.. J. Virol. 2022;96.
    pmc: PMC9769392pubmed: 36448796
  72. Li M, Kao E, Gao X, Sandig H, Limmer K, Pavon-Eternod M, Jones TE, Landry S, Pan T, Weitzman MD, David M. Codon-usage-based inhibition of hiv protein synthesis by human schlafen 11.. Nature 2012;491:125–128.
    pmc: PMC3705913pubmed: 23000900
  73. Li S, Ahmad I, Shi J, Wang B, Yu C, Zhang L, Zheng YH. Murine leukemia virus glycosylated gag reduces murine serinc5 protein expression at steady-state levels via the endosome/lysosome pathway to counteract serinc5 antiretroviral activity.. J. Virol. 2019;93.
    pmc: PMC6321930pubmed: 30355687
  74. Li W, Zhang Z, Zhang L, Li H, Fan S, Zhu E, Fan J, Li Z, Chen W, Yi L, Ding H, Chen J, Zhao M. Antiviral role of serine incorporator 5 (serinc5) proteins in classical swine fever virus infection.. Front. Microbiol. 2020;11.
    pmc: PMC7498654pubmed: 33013817
  75. Lim ES, Wu LI, Malik HS, Emerman M. The function and evolution of the restriction factor viperin in primates was not driven by lentiviruses.. Retrovirology 2012;9:55.
    pmc: PMC3414838pubmed: 22734835
  76. Lin Y, Wang XF, Wang Y, Du C, Ren H, Liu C, Zhu D, Chen J, Na L, Liu D, Yang Z, Wang X. Env diversity-dependent protection of the attenuated equine infectious anaemia virus vaccine.. Emerg. Microb. Infect. 2020;9:1309–1320.
    pmc: PMC7473056pubmed: 32525460
  77. Lin YZ, Cao XZ, Li L, Li L, Jiang CG, Wang XF, Ma J, Zhou JH. The pathogenic and vaccine strains of equine infectious anemia virus differentially induce cytokine and chemokine expression and apoptosis in macrophages.. Virus Res. 2011;160:274–282.
    pubmed: 21782860
  78. Lin YZ, Sun LK, Zhu DT, Hu Z, Wang XF, Du C, Wang YH, Wang XJ, Zhou JH. Equine schlafen 11 restricts the production of equine infectious anemia virus via a codon usage-dependent mechanism.. Virology 2016;495:112–121.
    pubmed: 27200480
  79. Lin YZ, Shen RX, Zhu ZY, Deng XL, Cao XZ, Wang XF, Ma J, Jiang CG, Zhao LP, Lv XL, Shao YM, Zhou JH. An attenuated eiav vaccine strain induces significantly different immune responses from its pathogenic parental strain although with similar in vivo replication pattern.. Antivir. Res. 2011;92:292–304.
    pubmed: 21893100
  80. Liu Y, Wang H, Zhang J, Yang J, Bai L, Zheng B, Zheng T, Wang Y, Li J, Zhang W. Serinc5 inhibits the secretion of complete and genome-free hepatitis b virions through interfering with the glycosylation of the hbv envelope.. Front. Microbiol. 2020;11:697.
    pmc: PMC7216740pubmed: 32431673
  81. Liu Z, Pan Q, Ding S, Qian J, Xu F, Zhou J, Cen S, Guo F, Liang C. The interferon-inducible mxb protein inhibits hiv-1 infection.. Cell Host Microbe 2013;14:398–410.
    pubmed: 24055605
  82. Malim MH, Bieniasz PD. Hiv restriction factors and mechanisms of evasion.. Cold Spring Harb Perspect Med. 2012;2.
    pmc: PMC3331687pubmed: 22553496
  83. Mangeat B, Turelli P, Caron G, Friedli M, Perrin L, Trono D. Broad antiretroviral defence by human apobec3g through lethal editing of nascent reverse transcripts.. Nature 2003;424:99–103.
    pubmed: 12808466
  84. Martinat C, Cormier A, Tobaly-Tapiero J, Palmic N, Casartelli N, Mahboubi B, Coggins SA, Buchrieser J, Persaud M, Diaz-Griffero F, Espert L, Bossis G, Lesage P, Schwartz O, Kim B, Margottin-Goguet F, Saib A, Zamborlini A. Sumoylation of samhd1 at lysine 595 is required for hiv-1 restriction in non-cycling cells.. Nat. Commun. 2021;12:4582.
    pmc: PMC8319325pubmed: 34321470
  85. Maury W. Monocyte maturation controls expression of equine infectious anemia virus.. J. Virol. 1994;68:6270–6279.
    pmc: PMC237047pubmed: 8083967
  86. McNatt MW, Zang T, Hatziioannou T, Bartlett M, Fofana IB, Johnson WE, Neil SJ, Bieniasz PD. Species-specific activity of hiv-1 vpu and positive selection of tetherin transmembrane domain variants.. PLoS Pathog. 2009;5.
    pmc: PMC2633611pubmed: 19214216
  87. Meier K, Jaguva Vasudevan AA, Zhang Z, Bahr A, Kochs G, Haussinger D, Munk C. Equine mx2 is a restriction factor of equine infectious anemia virus (eiav). Virology 2018;523:52–63.
    pubmed: 30081309
  88. Misumi Y, Misumi Y, Miki K, Takatsuki A, Tamura G, Ikehara Y. Novel blockade by brefeldin a of intracellular transport of secretory proteins in cultured rat hepatocytes.. J. Biol. Chem. 1986;261:11398–11403.
    pubmed: 2426273
  89. Mohamed A, Bakir T, Al-Hawel H, Al-Sharif I, Bakheet R, Kouser L, Murugaiah V, Al-Mozaini M. Hiv-2 vpx neutralizes host restriction factor samhd1 to promote viral pathogenesis.. Sci. Rep. 2021;11.
    pmc: PMC8545964pubmed: 34697376
  90. Morrison JH, Poeschla EM. The feline immunodeficiency virus envelope signal peptide is a tetherin antagonizing protein.. mBio 2023;14.
    pmc: PMC10128041pubmed: 36927083
  91. Morrison JH, Guevara RB, Marcano AC, Saenz DT, Fadel HJ, Rogstad DK, Poeschla EM. Feline immunodeficiency virus envelope glycoproteins antagonize tetherin through a distinctive mechanism that requires virion incorporation.. J. Virol. 2014;88:3255–3272.
    pmc: PMC3957917pubmed: 24390322
  92. Na L, Tang YD, Wang C, Liu C, Wang X. Rhesus monkey trim5alpha protein spry domain contributes to ap-1 activation.. J. Biol. Chem. 2018;293:2661–2674.
    pmc: PMC5827426pubmed: 29196608
  93. Nasr N, Maddocks S, Turville SG, Harman AN, Woolger N, Helbig KJ, Wilkinson J, Bye CR, Wright TK, Rambukwelle D, Donaghy H, Beard MR, Cunningham AL. Hiv-1 infection of human macrophages directly induces viperin which inhibits viral production.. Blood 2012;120:778–788.
    pubmed: 22677126
  94. Neil SJ, Zang T, Bieniasz PD. Tetherin inhibits retrovirus release and is antagonized by hiv-1 vpu.. Nature 2008;451:425–430.
    pubmed: 18200009
  95. Neil SJ, Sandrin V, Sundquist WI, Bieniasz PD. An interferon-alpha-induced tethering mechanism inhibits hiv-1 and ebola virus particle release but is counteracted by the hiv-1 vpu protein.. Cell Host Microbe 2007;2:193–203.
    pmc: PMC3793644pubmed: 18005734
  96. Nightingale K, Potts M, Hunter LM, Fielding CA, Zerbe CM, Fletcher-Etherington A, Nobre L, Wang ECY, Strang BL, Houghton JW, Antrobus R, Suarez NM, Nichols J, Davison AJ, Stanton RJ, Weekes MP. Human cytomegalovirus protein rl1 degrades the antiviral factor slfn11 via recruitment of the crl4 e3 ubiquitin ligase complex.. Proceedings of the National Academy of Sciences U S A vol. 119. 2022.
    pmc: PMC8832970pubmed: 35105802
  97. Nisole S, Lynch C, Stoye JP, Yap MW. A trim5-cyclophilin a fusion protein found in owl monkey kidney cells can restrict hiv-1. Proceedings of the National Academy of Sciences U S A Vol. 101. 2004. pp. 13324–13328.
    pmc: PMC516566pubmed: 15326303
  98. Oaks JL, McGuire TC, Ulibarri C, Crawford TB. Equine infectious anemia virus is found in tissue macrophages during subclinical infection.. J. Virol. 1998;72:7263–7269.
    pmc: PMC109949pubmed: 9696821
  99. Ooms M, Brayton B, Letko M, Maio SM, Pilcher CD, Hecht FM, Barbour JD, Simon V. Hiv-1 vif adaptation to human apobec3h haplotypes.. Cell Host Microbe 2013;14:411–421.
    pubmed: 24139399
  100. Ozato K, Shin DM, Chang TH, Morse HC 3rd. Trim family proteins and their emerging roles in innate immunity.. Nat. Rev. Immunol. 2008;8:849–860.
    pmc: PMC3433745pubmed: 18836477
  101. Panayiotou C, Lindqvist R, Kurhade C, Vonderstein K, Pasto J, Edlund K, Upadhyay AS, Overby AK. Viperin restricts zika virus and tick-borne encephalitis virus replication by targeting ns3 for proteasomal degradation.. J. Virol. 2018;92.
    pmc: PMC5972904pubmed: 29321318
  102. Passerini LD, Keckesova Z, Towers GJ. Retroviral restriction factors Fv1 and TRIM5alpha act independently and can compete for incoming virus before reverse transcription.. J Virol 2006 Mar;80(5):2100-5.
    pmc: PMC1395401pubmed: 16474118doi: 10.1128/jvi.80.5.2100-2105.2006google scholar: lookup
  103. Pauls E, Jimenez E, Ruiz A, Permanyer M, Ballana E, Costa H, Nascimiento R, Parkhouse RM, Peña R, Riveiro-Muñoz E, Martinez MA, Clotet B, Esté JA, Bofill M. Restriction of HIV-1 replication in primary macrophages by IL-12 and IL-18 through the upregulation of SAMHD1.. J Immunol 2013 May 1;190(9):4736-41.
    pubmed: 23526823doi: 10.4049/jimmunol.1203226google scholar: lookup
  104. Perez-Caballero D, Zang T, Ebrahimi A, McNatt MW, Gregory DA, Johnson MC, Bieniasz PD. Tetherin inhibits HIV-1 release by directly tethering virions to cells.. Cell 2009 Oct 30;139(3):499-511.
    pmc: PMC2844890pubmed: 19879838doi: 10.1016/j.cell.2009.08.039google scholar: lookup
  105. Pierini V, Gallucci L, Stürzel CM, Kirchhoff F, Fackler OT. SERINC5 Can Enhance Proinflammatory Cytokine Production by Primary Human Myeloid Cells in Response to Challenge with HIV-1 Particles.. J Virol 2021 Apr 12;95(9).
    pmc: PMC8104095pubmed: 33597208doi: 10.1128/jvi.02372-20google scholar: lookup
  106. Puck A, Aigner R, Modak M, Cejka P, Blaas D, Stöckl J. Expression and regulation of Schlafen (SLFN) family members in primary human monocytes, monocyte-derived dendritic cells and T cells.. Results Immunol 2015;5:23-32.
    pmc: PMC4625362pubmed: 26623250doi: 10.1016/j.rinim.2015.10.001google scholar: lookup
  107. Ren H, Yin X, Su C, Guo M, Wang XF, Na L, Lin Y, Wang X. Equine lentivirus counteracts SAMHD1 restriction by Rev-mediated degradation of SAMHD1 via the BECN1-dependent lysosomal pathway.. Autophagy 2021 Oct;17(10):2800-2817.
    pmc: PMC8525956pubmed: 33172327doi: 10.1080/15548627.2020.1846301google scholar: lookup
  108. Ribeiro CM, Sarrami-Forooshani R, Setiawan LC, Zijlstra-Willems EM, van Hamme JL, Tigchelaar W, van der Wel NN, Kootstra NA, Gringhuis SI, Geijtenbeek TB. Receptor usage dictates HIV-1 restriction by human TRIM5α in dendritic cell subsets.. Nature 2016 Dec 15;540(7633):448-452.
    pubmed: 27919079doi: 10.1038/nature20567google scholar: lookup
  109. Riess M, Fuchs NV, Idica A, Hamdorf M, Flory E, Pedersen IM, König R. Interferons Induce Expression of SAMHD1 in Monocytes through Down-regulation of miR-181a and miR-30a.. J Biol Chem 2017 Jan 6;292(1):264-277.
    pmc: PMC5217685pubmed: 27909056doi: 10.1074/jbc.m116.752584google scholar: lookup
  110. Rivera-Serrano EE, Gizzi AS, Arnold JJ, Grove TL, Almo SC, Cameron CE. Viperin Reveals Its True Function.. Annu Rev Virol 2020 Sep 29;7(1):421-446.
    pmc: PMC8191541pubmed: 32603630doi: 10.1146/annurev-virology-011720-095930google scholar: lookup
  111. Rollason R, Korolchuk V, Hamilton C, Schu P, Banting G. Clathrin-mediated endocytosis of a lipid-raft-associated protein is mediated through a dual tyrosine motif.. J Cell Sci 2007 Nov 1;120(Pt 21):3850-8.
    pubmed: 17940069doi: 10.1242/jcs.003343google scholar: lookup
  112. Rosa A, Chande A, Ziglio S, De Sanctis V, Bertorelli R, Goh SL, McCauley SM, Nowosielska A, Antonarakis SE, Luban J, Santoni FA, Pizzato M. HIV-1 Nef promotes infection by excluding SERINC5 from virion incorporation.. Nature 2015 Oct 8;526(7572):212-7.
    pmc: PMC4861059pubmed: 26416734doi: 10.1038/nature15399google scholar: lookup
  113. Rose KM, Spada SJ, Broeckel R, McNally KL, Hirsch VM, Best SM, Bouamr F. From Capsids to Complexes: Expanding the Role of TRIM5α in the Restriction of Divergent RNA Viruses and Elements.. Viruses 2021 Mar 10;13(3).
    pmc: PMC7998678pubmed: 33801908doi: 10.3390/v13030446google scholar: lookup
  114. Rosin-Arbesfeld R, Rivlin M, Noiman S, Mashiah P, Yaniv A, Miki T, Tronick SR, Gazit A. Structural and functional characterization of rev-like transcripts of equine infectious anemia virus.. J Virol 1993 Sep;67(9):5640-6.
    pmc: PMC237968pubmed: 8394464doi: 10.1128/jvi.67.9.5640-5646.1993google scholar: lookup
  115. Sakuma R, Noser JA, Ohmine S, Ikeda Y. Rhesus monkey TRIM5alpha restricts HIV-1 production through rapid degradation of viral Gag polyproteins.. Nat Med 2007 May;13(5):631-5.
    pubmed: 17435772doi: 10.1038/nm1562google scholar: lookup
  116. Sauter D. Counteraction of the multifunctional restriction factor tetherin.. Front Microbiol 2014;5:163.
    pmc: PMC3989765pubmed: 24782851doi: 10.3389/fmicb.2014.00163google scholar: lookup
  117. Schott K, Fuchs NV, Derua R, Mahboubi B, Schnellbächer E, Seifried J, Tondera C, Schmitz H, Shepard C, Brandariz-Nuñez A, Diaz-Griffero F, Reuter A, Kim B, Janssens V, König R. Dephosphorylation of the HIV-1 restriction factor SAMHD1 is mediated by PP2A-B55α holoenzymes during mitotic exit.. Nat Commun 2018 Jun 8;9(1):2227.
    pmc: PMC5993806pubmed: 29884836doi: 10.1038/s41467-018-04671-1google scholar: lookup
  118. Sellon DC, Perry ST, Coggins L, Fuller FJ. Wild-type equine infectious anemia virus replicates in vivo predominantly in tissue macrophages, not in peripheral blood monocytes.. J Virol 1992 Oct;66(10):5906-13.
    pmc: PMC241467pubmed: 1382143doi: 10.1128/jvi.66.10.5906-5913.1992google scholar: lookup
  119. Seo JY, Yaneva R, Cresswell P. Viperin: a multifunctional, interferon-inducible protein that regulates virus replication.. Cell Host Microbe 2011 Dec 15;10(6):534-9.
    pmc: PMC3246677pubmed: 22177558doi: 10.1016/j.chom.2011.11.004google scholar: lookup
  120. Sheehy AM, Gaddis NC, Choi JD, Malim MH. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein.. Nature 2002 Aug 8;418(6898):646-50.
    pubmed: 12167863doi: 10.1038/nature00939google scholar: lookup
  121. Shen T, Liang H, Tong X, Fan X, He X, Ma Y, Xiang W, Shen R, Zhang X, Shao Y. Amino acid mutations of the infectious clone from Chinese EIAV attenuated vaccine resulted in reversion of virulence.. Vaccine 2006 Feb 6;24(6):738-49.
    pubmed: 16202485doi: 10.1016/j.vaccine.2005.08.084google scholar: lookup
  122. Solbakken MH, Rise ML, Jakobsen KS, Jentoft S. Successive Losses of Central Immune Genes Characterize the Gadiformes' Alternate Immunity.. Genome Biol Evol 2016 Dec 31;8(11):3508-3515.
    pmc: PMC5203787pubmed: 27797950doi: 10.1093/gbe/evw250google scholar: lookup
  123. Sood C, Marin M, Chande A, Pizzato M, Melikyan GB. SERINC5 protein inhibits HIV-1 fusion pore formation by promoting functional inactivation of envelope glycoproteins.. J Biol Chem 2017 Apr 7;292(14):6014-6026.
    pmc: PMC5392591pubmed: 28179429doi: 10.1074/jbc.m117.777714google scholar: lookup
  124. St Gelais C, de Silva S, Amie SM, Coleman CM, Hoy H, Hollenbaugh JA, Kim B, Wu L. SAMHD1 restricts HIV-1 infection in dendritic cells (DCs) by dNTP depletion, but its expression in DCs and primary CD4+ T-lymphocytes cannot be upregulated by interferons.. Retrovirology 2012 Dec 11;9:105.
    pmc: PMC3527137pubmed: 23231760doi: 10.1186/1742-4690-9-105google scholar: lookup
  125. Steiner F, Pavlovic J. Subcellular Localization of MxB Determines Its Antiviral Potential against Influenza A Virus.. J Virol 2020 Oct 27;94(22).
    pmc: PMC7592211pubmed: 32907985doi: 10.1128/jvi.00125-20google scholar: lookup
  126. Stremlau M, Owens CM, Perron MJ, Kiessling M, Autissier P, Sodroski J. The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys.. Nature 2004 Feb 26;427(6977):848-53.
    pubmed: 14985764doi: 10.1038/nature02343google scholar: lookup
  127. Stremlau M, Perron M, Lee M, Li Y, Song B, Javanbakht H, Diaz-Griffero F, Anderson DJ, Sundquist WI, Sodroski J. Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5alpha restriction factor.. Proc Natl Acad Sci U S A 2006 Apr 4;103(14):5514-9.
    pmc: PMC1459386pubmed: 16540544doi: 10.1073/pnas.0509996103google scholar: lookup
  128. Szaniawski MA, Spivak AM, Cox JE, Catrow JL, Hanley T, Williams ESCP, Tremblay MJ, Bosque A, Planelles V. SAMHD1 Phosphorylation Coordinates the Anti-HIV-1 Response by Diverse Interferons and Tyrosine Kinase Inhibition.. mBio 2018 May 15;9(3).
    pmc: PMC5954222pubmed: 29764952doi: 10.1128/mbio.00819-18google scholar: lookup
  129. Tang YD, Zhang X, Na L, Wang XF, Fu LH, Zhu CH, Wang X, Zhou JH. Double-stranded-RNA-specific adenosine deaminase 1 (ADAR1) is proposed to contribute to the adaptation of equine infectious anemia virus from horses to donkeys.. Arch Virol 2016 Oct;161(10):2667-72.
    pubmed: 27383210doi: 10.1007/s00705-016-2951-3google scholar: lookup
  130. Tang YD, Na L, Zhu CH, Shen N, Yang F, Fu XQ, Wang YH, Fu LH, Wang JY, Lin YZ, Wang XF, Wang X, Zhou JH, Li CY. Equine viperin restricts equine infectious anemia virus replication by inhibiting the production and/or release of viral Gag, Env, and receptor via distortion of the endoplasmic reticulum.. J Virol 2014 Nov;88(21):12296-310.
    pmc: PMC4248950pubmed: 25122784doi: 10.1128/jvi.01379-14google scholar: lookup
  131. Timilsina U, Umthong S, Ivey EB, Waxman B, Stavrou S. SARS-CoV-2 ORF7a potently inhibits the antiviral effect of the host factor SERINC5.. Nat Commun 2022 May 26;13(1):2935.
    pmc: PMC9135752pubmed: 35618710doi: 10.1038/s41467-022-30609-9google scholar: lookup
  132. Turelli P, Mangeat B, Jost S, Vianin S, Trono D. Inhibition of hepatitis B virus replication by APOBEC3G.. Science 2004 Mar 19;303(5665):1829.
    pubmed: 15031497doi: 10.1126/science.1092066google scholar: lookup
  133. Uriu K, Kosugi Y, Ito J, Sato K. The Battle between Retroviruses and APOBEC3 Genes: Its Past and Present.. Viruses 2021 Jan 17;13(1).
    pmc: PMC7830460pubmed: 33477360doi: 10.3390/v13010124google scholar: lookup
  134. Usami Y, Wu Y, Göttlinger HG. SERINC3 and SERINC5 restrict HIV-1 infectivity and are counteracted by Nef.. Nature 2015 Oct 8;526(7572):218-23.
    pmc: PMC4600458pubmed: 26416733doi: 10.1038/nature15400google scholar: lookup
  135. Valdez F, Salvador J, Palermo PM, Mohl JE, Hanley KA, Watts D, Llano M. Schlafen 11 Restricts Flavivirus Replication.. J Virol 2019 Aug 1;93(15).
    pmc: PMC6639263pubmed: 31118262doi: 10.1128/jvi.00104-19google scholar: lookup
  136. Van Damme N, Goff D, Katsura C, Jorgenson RL, Mitchell R, Johnson MC, Stephens EB, Guatelli J. The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein.. Cell Host Microbe 2008 Apr 17;3(4):245-52.
    pmc: PMC2474773pubmed: 18342597doi: 10.1016/j.chom.2008.03.001google scholar: lookup
  137. Venkatesh S, Bieniasz PD. Mechanism of HIV-1 virion entrapment by tetherin.. PLoS Pathog 2013;9(7):e1003483.
    pmc: PMC3715405pubmed: 23874200doi: 10.1371/journal.ppat.1003483google scholar: lookup
  138. Verhelst J, Hulpiau P, Saelens X. Mx proteins: antiviral gatekeepers that restrain the uninvited.. Microbiol Mol Biol Rev 2013 Dec;77(4):551-66.
    pmc: PMC3973384pubmed: 24296571doi: 10.1128/mmbr.00024-13google scholar: lookup
  139. Vonderstein K, Nilsson E, Hubel P, Nygård Skalman L, Upadhyay A, Pasto J, Pichlmair A, Lundmark R, Överby AK. Viperin Targets Flavivirus Virulence by Inducing Assembly of Noninfectious Capsid Particles.. J Virol 2018 Jan 1;92(1).
    pmc: PMC5730767pubmed: 29046456doi: 10.1128/jvi.01751-17google scholar: lookup
  140. Wang C, Zhang K, Meng L, Zhang X, Song Y, Zhang Y, Gai Y, Zhang Y, Yu B, Wu J, Wang S, Yu X. The C-terminal domain of feline and bovine SAMHD1 proteins has a crucial role in lentiviral restriction.. J Biol Chem 2020 Mar 27;295(13):4252-4264.
    pmc: PMC7105322pubmed: 32075911doi: 10.1074/jbc.ra120.012767google scholar: lookup
  141. Wang W, Wang J, Qu M, Li X, Zhang J, Zhang H, Wu J, Yu B, Wu H, Kong W, Yu X. Viral Restriction Activity of Feline BST2 Is Independent of Its N-Glycosylation and Induction of NF-κB Activation.. PLoS One 2015;10(9):e0138190.
    pmc: PMC4574558pubmed: 26379128doi: 10.1371/journal.pone.0138190google scholar: lookup
  142. Wang X, Hinson ER, Cresswell P. The interferon-inducible protein viperin inhibits influenza virus release by perturbing lipid rafts.. Cell Host Microbe 2007 Aug 16;2(2):96-105.
    pubmed: 18005724doi: 10.1016/j.chom.2007.06.009google scholar: lookup
  143. Wang X, Wang S, Lin Y, Jiang C, Ma J, Zhao L, Lv X, Wang F, Shen R, Kong X, Zhou J. Genomic comparison between attenuated Chinese equine infectious anemia virus vaccine strains and their parental virulent strains.. Arch Virol 2011 Feb;156(2):353-7.
    pubmed: 21136127doi: 10.1007/s00705-010-0877-8google scholar: lookup
  144. Wang XF, Bai B, Lin Y, Qi T, Du C, Song M, Wang X. High-Efficiency Rescue of Equine Infectious Anemia Virus from a CMV-Driven Infectious Clone.. Virol Sin 2019 Dec;34(6):725-728.
    pmc: PMC6888787pubmed: 31376080doi: 10.1007/s12250-019-00153-wgoogle scholar: lookup
  145. Wang XF, Wang YH, Bai B, Zhang M, Chen J, Zhang X, Gao M, Wang X. Truncation of the Cytoplasmic Tail of Equine Infectious Anemia Virus Increases Virion Production by Improving Env Cleavage and Plasma Membrane Localization.. J Virol 2021 Nov 9;95(23):e0108721.
    pmc: PMC8577380pubmed: 34495693doi: 10.1128/jvi.01087-21google scholar: lookup
  146. Wang XF, Lin YZ, Li Q, Liu Q, Zhao WW, Du C, Chen J, Wang X, Zhou JH. Genetic Evolution during the development of an attenuated EIAV vaccine.. Retrovirology 2016 Feb 3;13:9.
    pmc: PMC4738788pubmed: 26842878doi: 10.1186/s12977-016-0240-6google scholar: lookup
  147. Wang Y, Zhang H, Na L, Du C, Zhang Z, Zheng YH, Wang X. ANP32A and ANP32B are key factors in the Rev-dependent CRM1 pathway for nuclear export of HIV-1 unspliced mRNA.. J Biol Chem 2019 Oct 18;294(42):15346-15357.
    pmc: PMC6802516pubmed: 31444273doi: 10.1074/jbc.ra119.008450google scholar: lookup
  148. Wang Y, Ma G, Wang XF, Na L, Guo X, Zhang J, Liu C, Du C, Qi T, Lin Y, Wang X. Keap1 recognizes EIAV early accessory protein Rev to promote antiviral defense.. PLoS Pathog 2022 Feb;18(2):e1009986.
    pmc: PMC8863222pubmed: 35139135doi: 10.1371/journal.ppat.1009986google scholar: lookup
  149. Wang Z, Chai K, Liu Q, Yi DR, Pan Q, Huang Y, Tan J, Qiao W, Guo F, Cen S, Liang C. HIV-1 resists MxB inhibition of viral Rev protein.. Emerg Microbes Infect 2020 Dec;9(1):2030-2045.
    pmc: PMC7534208pubmed: 32873191doi: 10.1080/22221751.2020.1818633google scholar: lookup
  150. Weinstein AG, Godet I, Gilkes DM. The rise of viperin: the emerging role of viperin in cancer progression.. J Clin Invest 2022 Dec 15;132(24).
    pmc: PMC9753986pubmed: 36519538doi: 10.1172/jci165907google scholar: lookup
  151. Welbourn S, Dutta SM, Semmes OJ, Strebel K. Restriction of virus infection but not catalytic dNTPase activity is regulated by phosphorylation of SAMHD1.. J Virol 2013 Nov;87(21):11516-24.
    pmc: PMC3807338pubmed: 23966382doi: 10.1128/jvi.01642-13google scholar: lookup
  152. White TE, Brandariz-Nuñez A, Valle-Casuso JC, Amie S, Nguyen LA, Kim B, Tuzova M, Diaz-Griffero F. The retroviral restriction ability of SAMHD1, but not its deoxynucleotide triphosphohydrolase activity, is regulated by phosphorylation.. Cell Host Microbe 2013 Apr 17;13(4):441-51.
    pmc: PMC3864637pubmed: 23601106doi: 10.1016/j.chom.2013.03.005google scholar: lookup
  153. Xu S, Zheng Z, Pathak JL, Cheng H, Zhou Z, Chen Y, Wu Q, Wang L, Zeng M, Wu L. The Emerging Role of the Serine Incorporator Protein Family in Regulating Viral Infection.. Front Cell Dev Biol 2022;10:856468.
    pmc: PMC9010877pubmed: 35433679doi: 10.3389/fcell.2022.856468google scholar: lookup
  154. Xue-Feng Wang, Lin Yuezhi, Cheng Du, Wang Xiaojun. Research progress on attenuation and immune protection mechanism of an attenuated equine infectious anemia virus vaccine.. Chin. Bull. Life Sci. 2022;33:10.
  155. Yao Q, Ma J, Wang X, Guo M, Li Y, Wang X. A pilot study on interaction between donkey tetherin and EIAV stains with different virulent and replication characteristics.. Microb Pathog 2017 May;106:65-68.
    pubmed: 27816678doi: 10.1016/j.micpath.2016.10.019google scholar: lookup
  156. Yi DR, An N, Liu ZL, Xu FW, Raniga K, Li QJ, Zhou R, Wang J, Zhang YX, Zhou JM, Zhang LL, An J, Qin CF, Guo F, Li XY, Liang C, Cen S. Human MxB Inhibits the Replication of Hepatitis C Virus.. J Virol 2019 Jan 1;93(1).
    pmc: PMC6288330pubmed: 30333168doi: 10.1128/jvi.01285-18google scholar: lookup
  157. Yin X, Hu Z, Gu Q, Wu X, Zheng YH, Wei P, Wang X. Equine tetherin blocks retrovirus release and its activity is antagonized by equine infectious anemia virus envelope protein.. J Virol 2014 Jan;88(2):1259-70.
    pmc: PMC3911658pubmed: 24227834doi: 10.1128/jvi.03148-13google scholar: lookup
  158. Yu M, Sun L, Zhang Z, Zhang Y, Zhang H, Na L, Wang X. KPNA6 is a Cofactor of ANP32A/B in Supporting Influenza Virus Polymerase Activity.. Microbiol Spectr 2022 Feb 23;10(1):e0207321.
    pmc: PMC8768627pubmed: 35044222doi: 10.1128/spectrum.02073-21google scholar: lookup
  159. Yu Q, König R, Pillai S, Chiles K, Kearney M, Palmer S, Richman D, Coffin JM, Landau NR. Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome.. Nat Struct Mol Biol 2004 May;11(5):435-42.
    pubmed: 15098018doi: 10.1038/nsmb758google scholar: lookup
  160. Yu X, Matsuda Z, Yu QC, Lee TH, Essex M. Vpx of simian immunodeficiency virus is localized primarily outside the virus core in mature virions.. J Virol 1993 Jul;67(7):4386-90.
    pmc: PMC237811pubmed: 8510227doi: 10.1128/jvi.67.7.4386-4390.1993google scholar: lookup
  161. Zhang F, Landford WN, Ng M, McNatt MW, Bieniasz PD, Hatziioannou T. SIV Nef proteins recruit the AP-2 complex to antagonize Tetherin and facilitate virion release.. PLoS Pathog 2011 May;7(5):e1002039.
    pmc: PMC3098198pubmed: 21625568doi: 10.1371/journal.ppat.1002039google scholar: lookup
  162. Zhang F, Wilson SJ, Landford WC, Virgen B, Gregory D, Johnson MC, Munch J, Kirchhoff F, Bieniasz PD, Hatziioannou T. Nef proteins from simian immunodeficiency viruses are tetherin antagonists.. Cell Host Microbe 2009 Jul 23;6(1):54-67.
    pmc: PMC2852097pubmed: 19501037doi: 10.1016/j.chom.2009.05.008google scholar: lookup
  163. Zhang H, Zhang Z, Wang Y, Wang M, Wang X, Zhang X, Ji S, Du C, Chen H, Wang X. Fundamental Contribution and Host Range Determination of ANP32A and ANP32B in Influenza A Virus Polymerase Activity.. J Virol 2019 Jul 1;93(13).
    pmc: PMC6580979pubmed: 30996088doi: 10.1128/jvi.00174-19google scholar: lookup
  164. Zhang X, Wang Y, Liang H, Wei L, Xiang W, Shen R, Shao Y. Correlation between the induction of Th1 cytokines by an attenuated equine infectious anemia virus vaccine and protection against disease progression.. J Gen Virol 2007 Mar;88(Pt 3):998-1004.
    pubmed: 17325374doi: 10.1099/vir.0.82416-0google scholar: lookup
  165. Zhang X, Li J, Zhang M, Bai B, Ma W, Lin Y, Guo X, Wang XF, Wang X. A Novel, Fully Spliced, Accessory Gene in Equine Lentivirus with Distinct Rev-Responsive Element.. J Virol 2022 Sep 28;96(18):e0098622.
    pmc: PMC9517694pubmed: 36069548doi: 10.1128/jvi.00986-22google scholar: lookup
  166. Zhang X, Zhou T, Yang J, Lin Y, Shi J, Zhang X, Frabutt DA, Zeng X, Li S, Venta PJ, Zheng YH. Identification of SERINC5-001 as the Predominant Spliced Isoform for HIV-1 Restriction.. J Virol 2017 May 15;91(10).
    pmc: PMC5411613pubmed: 28275190doi: 10.1128/jvi.00137-17google scholar: lookup
  167. Zhao F, Xu F, Liu X, Hu Y, Wei L, Fan Z, Wang L, Huang Y, Mei S, Guo L, Yang L, Cen S, Wang J, Liang C, Guo F. SERINC5 restricts influenza virus infectivity.. PLoS Pathog 2022 Oct;18(10):e1010907.
    pmc: PMC9591065pubmed: 36223419doi: 10.1371/journal.ppat.1010907google scholar: lookup
  168. Zielonka J, Bravo IG, Marino D, Conrad E, Perković M, Battenberg M, Cichutek K, Münk C. Restriction of equine infectious anemia virus by equine APOBEC3 cytidine deaminases.. J Virol 2009 Aug;83(15):7547-59.
    pmc: PMC2708611pubmed: 19458006doi: 10.1128/jvi.00015-09google scholar: lookup

Citations

This article has been cited 0 times.
Subscribe to our newsletter
Join 99,344 horse owners like you who receive our email updates on horse health and nutrition.